Asia Pacific Depression Screening Market Trends

Customize Your Report Customize Your Report Buy Now Buy Now Free Sample Report Free Sample Report
Home Healthcare Asia Pacific Depression Screening Market Market Trends
Request for TOC Request for TOC Speak to Analyst Speak to Analyst Buy Now Buy Now Inquire Before Buying Inquire Before Free Sample Report Free Sample Report

Asia Trends

  • Healthcare
  • Published Report
  • Oct 2024
  • Asia-Pacific
  • 350 Pages
  • No of Tables: 128
  • No of Figures: 30
Buy Now Buy Now

“Rise in Focus on Integration of Digital and Mobile Health Screening Tools”

The prominent trend in the Asia-Pacific depression screening market is the growing integration of digital and mobile health screening tools to increase accessibility and early diagnosis. With the rising penetration of smartphones and internet access across the region, digital health platforms are offering mental health screening tools that make it easier for individuals to access resources without visiting a clinical setting. This trend is particularly relevant in countries where mental health stigma remains a barrier to seeking in-person care. By providing online questionnaires and self-assessment tools, digital platforms are empowering users to evaluate their mental health status confidentially and take the first step toward seeking professional help if needed. The convenience and privacy offered by digital screening tools are significantly expanding the reach of mental health services, especially among younger, tech-savvy populations.

Governments and healthcare organizations in countries such as Japan, China, and India are increasingly recognizing the potential of these tools and are partnering with digital health companies to support awareness campaigns and broaden mental health service delivery. The COVID-19 pandemic has further accelerated this shift, highlighting the importance of accessible mental health resources. Various mobile applications and telemedicine services have emerged, incorporating depression screening as a core feature. This trend not only aligns with the region’s digital health initiatives but also provides a scalable solution to address the growing mental health crisis, facilitating early intervention and potentially reducing the burden on healthcare systems.

Table of Content

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF THE ASIA-PACIFIC DEPRESSION SCREENING MARKET

1.4 CURRENCY AND PRICING

1.5 LIMITATIONS

1.6 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 DBMR TRIPOD DATA VALIDATION MODEL

2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.6 MULTIVARIATE MODELLING

2.7 MARKET END-USER COVERAGE GRID

2.8 DEPRESSION TYPE LIFELINE CURVE

2.9 DBMR MARKET POSITION GRID

2.1 VENDOR SHARE ANALYSIS

2.11 SECONDARY SOURCES

2.12 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 PESTEL ANALYSIS

4.2 PORTER’S FIVE FORCES

5 APAC DEPRESSION SCREENING MARKET: REGULATIONS

5.1 REGULATORY AUTHORITIES IN ASIA-PACIFIC.

6 MARKET OVERVIEW

6.1 DRIVERS

6.1.1 INCREASING PREVALENCE OF DEPRESSION AND ANXIETY DISORDERS

6.1.2 ADVANCEMENTS IN DEPRESSION SCREENING TECHNOLOGY

6.1.3 INCREASING FOCUS ON MENTAL HEALTH IN THE WORKPLACE

6.2 RESTRAINTS

6.2.1 SHORTAGE OF MENTAL HEALTH PROFESSIONALS

6.2.2 LOW AWARENESS ABOUT DEPRESSION AND ITS SYMPTOMS

6.3 OPPORTUNITIES

6.3.1 INTEGRATION DEPRESSION SCREENINGS WITH PRIMARY CARE

6.3.2 GOVERNMENT AND HEALTHCARE ORGANIZATIONS ARE INCREASINGLY SUPPORTING MENTAL HEALTH INITIATIVES

6.3.3 INCREASING ADOPTION OF TELEHEALTH SERVICES FOR REMOTE DEPRESSION SCREENING

6.4 CHALLENGES

6.4.1 PERSISTENT STIGMA AROUND MENTAL HEALTH

6.4.2 SAFEGUARDING THE PRIVACY AND SECURITY OF SENSITIVE MENTAL HEALTH DATA

7 ASIA-PACIFIC DEPRESSION SCREENING MARKET, BY DEPRESSION TYPE

7.1 OVERVIEW

7.2 MAJOR DEPRESSIVE DISORDER (MDD)

7.3 PERSISTENT DEPRESSIVE DISORDER (PDD)

7.4 OTHERS

8 ASIA-PACIFIC DEPRESSION SCREENING MARKET, BY DIAGNOSIS

8.1 OVERVIEW

8.2 SCREENING

8.2.1 CLINICAL

8.2.2 NON-CLINICAL

8.2.2.1 TELEMEDICINE PLATFORMS

8.2.2.2 BRAINWAVE ASSESSMENT TOOLS

8.2.2.3 OTHERS

8.2.2.3.1 PHQ-9 (PATIENT HEALTH QUESTIONNAIRE-9)

8.2.2.3.2 BECK DEPRESSION INVENTORY (BDI)

8.2.2.3.3 PSYCHOLOGICAL TEST

8.2.2.3.4 GERIATRIC DEPRESSION SCALE (GDS)

8.3 LAB TESTS

8.3.1 GENETIC TEST

8.3.2 BIO MARKER TEST

8.3.3 OTHERS

9 ASIA-PACIFIC DEPRESSION SCREENING MARKET, BY END-USER

9.1 OVERVIEW

9.2 HOSPITAL

9.2.1 PRIVATE

9.2.2 PUBLIC

9.2.2.1 LARGE-SIZE HOSPITALS

9.2.2.2 MEDIUM-SIZE HOSPITALS

9.2.2.3 SMALL-SIZE HOSPITALS

9.3 SPECIALTY CLINICS

9.4 MEDICAL RESEARCH CENTERS

9.5 OTHERS

10 ASIA-PACIFIC DEPRESSION SCREENING MARKET, BY COUNTRY

10.1 ASIA-PACIFIC

10.1.1 CHINA

10.1.2 JAPAN

10.1.3 INDIA

10.1.4 SOUTH KOREA

10.1.5 AUSTRALIA

10.1.6 INDONESIA

10.1.7 THAILAND

10.1.8 SINGAPORE

10.1.9 TAIWAN

10.1.10 MALAYSIA

10.1.11 VIETNAM

10.1.12 PHILIPPINES

10.1.13 REST OF ASIA-PACIFIC

11 ASIA-PACIFIC DEPRESSION SCREENING MARKET: COMPANY LANDSCAPE

11.1 COMPANY SHARE ANALYSIS: ASIA-PACIFIC

12 SWOT ANALYSIS

13 COMPANY PROFILES

13.1 KONINKLIJKE PHILIPS N.V.

13.1.1 COMPANY SNAPSHOT

13.1.2 REVENUE ANALYSIS

13.1.3 PRODUCT PORTFOLIO

13.1.4 RECENT DEVELOPMENT

13.2 APPLE INC.

13.2.1 COMPANY SNAPSHOT

13.2.2 REVENUE ANALYSIS

13.2.3 PRODUCT PORTFOLIO

13.2.4 RECENT DEVELOPMENTS

13.3 GOOGLE

13.3.1 COMPANY SNAPSHOT

13.3.2 REVENUE ANALYSIS

13.3.3 PRODUCT PORTFOLIO

13.3.4 RECENT DEVELOPMENT

13.4 LIFETRACK MEDICAL SYSTEMS

13.4.1 COMPANY SNAPSHOT

13.4.2 PRODUCT PORTFOLIO

13.4.3 RECENT DEVELOPMENT

13.5 GENETIC TECHNOLOGIES LIMITED

13.5.1 COMPANY SNAPSHOT

13.5.2 REVENUE ANALYSIS

13.5.3 PRODUCT PORTFOLIO

13.5.4 RECENT DEVELOPMENT

13.6 HEADSPACE INC.

13.6.1 COMPANY SNAPSHOT

13.6.2 PRODUCT PORTFOLIO

13.6.3 RECENT DEVELOPMENT

13.7 PANKHTECH INDIA PRIVATE LIMITED

13.7.1 COMPANY SNAPSHOT

13.7.2 PRODUCT PORTFOLIO

13.7.3 RECENT DEVELOPMENT

13.8 PEARSON

13.8.1 COMPANY SNAPSHOT

13.8.2 PRODUCT PORTFOLIO

13.8.3 RECENT DEVELOPMENT

14 QUESTIONNAIRE

15 RELATED REPORTS

List of Table

TABLE 1 ASIA-PACIFIC DEPRESSION SCREENING MARKET, BY DEPRESSION TYPE, 2022-2031 (USD MILLION)

TABLE 2 ASIA-PACIFIC DEPRESSION SCREENING MARKET, BY DIAGNOSIS, 2022-2031 (USD MILLION)

TABLE 3 ASIA-PACIFIC SCREENING IN DEPRESSION SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 4 ASIA-PACIFIC CLINICAL IN DEPRESSION SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 5 ASIA-PACIFIC NON-CLINICAL IN DEPRESSION SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 6 ASIA-PACIFIC LAB TESTS IN DEPRESSION SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 7 ASIA-PACIFIC DEPRESSION SCREENING MARKET, BY END-USER, 2022-2031 (USD MILLION)

TABLE 8 ASIA-PACIFIC HOSPITAL IN DEPRESSION SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 9 ASIA-PACIFIC HOSPITAL IN DEPRESSION SCREENING MARKET, BY SIZE, 2022-2031 (USD MILLION)

TABLE 10 ASIA-PACIFIC DEPRESSION SCREENING MARKET, BY COUNTRY, 2022-2031 (USD MILLION)

TABLE 11 ASIA-PACIFIC DEPRESSION SCREENING MARKET, BY DEPRESSION TYPE, 2022-2031 (USD MILLION)

TABLE 12 ASIA-PACIFIC DEPRESSION SCREENING MARKET, BY DIAGNOSIS, 2022-2031 (USD MILLION)

TABLE 13 ASIA-PACIFIC SCREENING IN DEPRESSION SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 14 ASIA-PACIFIC CLINICAL IN DEPRESSION SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 15 ASIA-PACIFIC NON-CLINICAL SCREENING IN DEPRESSION SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 16 ASIA-PACIFIC LAB TESTS IN DEPRESSION SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 17 ASIA-PACIFIC DEPRESSION SCREENING MARKET, BY END-USER, 2022-2031 (USD MILLION)

TABLE 18 ASIA-PACIFIC HOSPITAL IN DEPRESSION SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 19 ASIA-PACIFIC HOSPITAL IN DEPRESSION SCREENING MARKET, BY SIZE, 2022-2031 (USD MILLION)

TABLE 20 CHINA DEPRESSION SCREENING MARKET, BY DEPRESSION TYPE, 2022-2031 (USD MILLION)

TABLE 21 CHINA DEPRESSION SCREENING MARKET, BY DIAGNOSIS, 2022-2031 (USD MILLION)

TABLE 22 CHINA SCREENING IN DEPRESSION SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 23 CHINA CLINICAL IN DEPRESSION SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 24 CHINA NON-CLINICAL SCREENING IN DEPRESSION SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 25 CHINA LAB TESTS IN DEPRESSION SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 26 CHINA DEPRESSION SCREENING MARKET, BY END-USER, 2022-2031 (USD MILLION)

TABLE 27 CHINA HOSPITAL IN DEPRESSION SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 28 CHINA HOSPITAL IN DEPRESSION SCREENING MARKET, BY SIZE, 2022-2031 (USD MILLION)

TABLE 29 JAPAN DEPRESSION SCREENING MARKET, BY DEPRESSION TYPE, 2022-2031 (USD MILLION)

TABLE 30 JAPAN DEPRESSION SCREENING MARKET, BY DIAGNOSIS, 2022-2031 (USD MILLION)

TABLE 31 JAPAN SCREENING IN DEPRESSION SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 32 JAPAN CLINICAL IN DEPRESSION SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 33 JAPAN NON-CLINICAL SCREENING IN DEPRESSION SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 34 JAPAN LAB TESTS IN DEPRESSION SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 35 JAPAN DEPRESSION SCREENING MARKET, BY END-USER, 2022-2031 (USD MILLION)

TABLE 36 JAPAN HOSPITAL IN DEPRESSION SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 37 JAPAN HOSPITAL IN DEPRESSION SCREENING MARKET, BY SIZE, 2022-2031 (USD MILLION)

TABLE 38 INDIA DEPRESSION SCREENING MARKET, BY DEPRESSION TYPE, 2022-2031 (USD MILLION)

TABLE 39 INDIA DEPRESSION SCREENING MARKET, BY DIAGNOSIS, 2022-2031 (USD MILLION)

TABLE 40 INDIA SCREENING IN DEPRESSION SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 41 INDIA CLINICAL IN DEPRESSION SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 42 INDIA NON-CLINICAL SCREENING IN DEPRESSION SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 43 INDIA LAB TESTS IN DEPRESSION SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 44 INDIA DEPRESSION SCREENING MARKET, BY END-USER, 2022-2031 (USD MILLION)

TABLE 45 INDIA HOSPITAL IN DEPRESSION SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 46 INDIA HOSPITAL IN DEPRESSION SCREENING MARKET, BY SIZE, 2022-2031 (USD MILLION)

TABLE 47 SOUTH KOREA DEPRESSION SCREENING MARKET, BY DEPRESSION TYPE, 2022-2031 (USD MILLION)

TABLE 48 SOUTH KOREA DEPRESSION SCREENING MARKET, BY DIAGNOSIS, 2022-2031 (USD MILLION)

TABLE 49 SOUTH KOREA SCREENING IN DEPRESSION SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 50 SOUTH KOREA CLINICAL IN DEPRESSION SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 51 SOUTH KOREA NON-CLINICAL SCREENING IN DEPRESSION SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 52 SOUTH KOREA LAB TESTS IN DEPRESSION SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 53 SOUTH KOREA DEPRESSION SCREENING MARKET, BY END-USER, 2022-2031 (USD MILLION)

TABLE 54 SOUTH KOREA HOSPITAL IN DEPRESSION SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 55 SOUTH KOREA HOSPITAL IN DEPRESSION SCREENING MARKET, BY SIZE, 2022-2031 (USD MILLION)

TABLE 56 AUSTRALIA DEPRESSION SCREENING MARKET, BY DEPRESSION TYPE, 2022-2031 (USD MILLION)

TABLE 57 AUSTRALIA DEPRESSION SCREENING MARKET, BY DIAGNOSIS, 2022-2031 (USD MILLION)

TABLE 58 AUSTRALIA SCREENING IN DEPRESSION SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 59 AUSTRALIA CLINICAL IN DEPRESSION SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 60 AUSTRALIA NON-CLINICAL SCREENING IN DEPRESSION SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 61 AUSTRALIA LAB TESTS IN DEPRESSION SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 62 AUSTRALIA DEPRESSION SCREENING MARKET, BY END-USER, 2022-2031 (USD MILLION)

TABLE 63 AUSTRALIA HOSPITAL IN DEPRESSION SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 64 AUSTRALIA HOSPITAL IN DEPRESSION SCREENING MARKET, BY SIZE, 2022-2031 (USD MILLION)

TABLE 65 INDONESIA DEPRESSION SCREENING MARKET, BY DEPRESSION TYPE, 2022-2031 (USD MILLION)

TABLE 66 INDONESIA DEPRESSION SCREENING MARKET, BY DIAGNOSIS, 2022-2031 (USD MILLION)

TABLE 67 INDONESIA SCREENING IN DEPRESSION SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 68 INDONESIA CLINICAL IN DEPRESSION SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 69 INDONESIA NON-CLINICAL SCREENING IN DEPRESSION SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 70 INDONESIA LAB TESTS IN DEPRESSION SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 71 INDONESIA DEPRESSION SCREENING MARKET, BY END-USER, 2022-2031 (USD MILLION)

TABLE 72 INDONESIA HOSPITAL IN DEPRESSION SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 73 INDONESIA HOSPITAL IN DEPRESSION SCREENING MARKET, BY SIZE, 2022-2031 (USD MILLION)

TABLE 74 THAILAND DEPRESSION SCREENING MARKET, BY DEPRESSION TYPE, 2022-2031 (USD MILLION)

TABLE 75 THAILAND DEPRESSION SCREENING MARKET, BY DIAGNOSIS, 2022-2031 (USD MILLION)

TABLE 76 THAILAND SCREENING IN DEPRESSION SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 77 THAILAND CLINICAL IN DEPRESSION SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 78 THAILAND NON-CLINICAL SCREENING IN DEPRESSION SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 79 THAILAND LAB TESTS IN DEPRESSION SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 80 THAILAND DEPRESSION SCREENING MARKET, BY END-USER, 2022-2031 (USD MILLION)

TABLE 81 THAILAND HOSPITAL IN DEPRESSION SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 82 THAILAND HOSPITAL IN DEPRESSION SCREENING MARKET, BY SIZE, 2022-2031 (USD MILLION)

TABLE 83 SINGAPORE DEPRESSION SCREENING MARKET, BY DEPRESSION TYPE, 2022-2031 (USD MILLION)

TABLE 84 SINGAPORE DEPRESSION SCREENING MARKET, BY DIAGNOSIS, 2022-2031 (USD MILLION)

TABLE 85 SINGAPORE SCREENING IN DEPRESSION SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 86 SINGAPORE CLINICAL IN DEPRESSION SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 87 SINGAPORE NON-CLINICAL SCREENING IN DEPRESSION SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 88 SINGAPORE LAB TESTS IN DEPRESSION SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 89 SINGAPORE DEPRESSION SCREENING MARKET, BY END-USER, 2022-2031 (USD MILLION)

TABLE 90 SINGAPORE HOSPITAL IN DEPRESSION SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 91 SINGAPORE HOSPITAL IN DEPRESSION SCREENING MARKET, BY SIZE, 2022-2031 (USD MILLION)

TABLE 92 TAIWAN DEPRESSION SCREENING MARKET, BY DEPRESSION TYPE, 2022-2031 (USD MILLION)

TABLE 93 TAIWAN DEPRESSION SCREENING MARKET, BY DIAGNOSIS, 2022-2031 (USD MILLION)

TABLE 94 TAIWAN SCREENING IN DEPRESSION SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 95 TAIWAN CLINICAL IN DEPRESSION SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 96 TAIWAN NON-CLINICAL SCREENING IN DEPRESSION SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 97 TAIWAN LAB TESTS IN DEPRESSION SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 98 TAIWAN DEPRESSION SCREENING MARKET, BY END-USER, 2022-2031 (USD MILLION)

TABLE 99 TAIWAN HOSPITAL IN DEPRESSION SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 100 TAIWAN HOSPITAL IN DEPRESSION SCREENING MARKET, BY SIZE, 2022-2031 (USD MILLION)

TABLE 101 MALAYSIA DEPRESSION SCREENING MARKET, BY DEPRESSION TYPE, 2022-2031 (USD MILLION)

TABLE 102 MALAYSIA DEPRESSION SCREENING MARKET, BY DIAGNOSIS, 2022-2031 (USD MILLION)

TABLE 103 MALAYSIA SCREENING IN DEPRESSION SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 104 MALAYSIA CLINICAL IN DEPRESSION SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 105 MALAYSIA NON-CLINICAL SCREENING IN DEPRESSION SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 106 MALAYSIA LAB TESTS IN DEPRESSION SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 107 MALAYSIA DEPRESSION SCREENING MARKET, BY END-USER, 2022-2031 (USD MILLION)

TABLE 108 MALAYSIA HOSPITAL IN DEPRESSION SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 109 MALAYSIA HOSPITAL IN DEPRESSION SCREENING MARKET, BY SIZE, 2022-2031 (USD MILLION)

TABLE 110 VIETNAM DEPRESSION SCREENING MARKET, BY DEPRESSION TYPE, 2022-2031 (USD MILLION)

TABLE 111 VIETNAM DEPRESSION SCREENING MARKET, BY DIAGNOSIS, 2022-2031 (USD MILLION)

TABLE 112 VIETNAM SCREENING IN DEPRESSION SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 113 VIETNAM CLINICAL IN DEPRESSION SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 114 VIETNAM NON-CLINICAL SCREENING IN DEPRESSION SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 115 VIETNAM LAB TESTS IN DEPRESSION SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 116 VIETNAM DEPRESSION SCREENING MARKET, BY END-USER, 2022-2031 (USD MILLION)

TABLE 117 VIETNAM HOSPITAL IN DEPRESSION SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 118 VIETNAM HOSPITAL IN DEPRESSION SCREENING MARKET, BY SIZE, 2022-2031 (USD MILLION)

TABLE 119 PHILIPPINES DEPRESSION SCREENING MARKET, BY DEPRESSION TYPE, 2022-2031 (USD MILLION)

TABLE 120 PHILIPPINES DEPRESSION SCREENING MARKET, BY DIAGNOSIS, 2022-2031 (USD MILLION)

TABLE 121 PHILIPPINES SCREENING IN DEPRESSION SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 122 PHILIPPINES CLINICAL IN DEPRESSION SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 123 PHILIPPINES NON-CLINICAL SCREENING IN DEPRESSION SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 124 PHILIPPINES LAB TESTS IN DEPRESSION SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 125 PHILIPPINES DEPRESSION SCREENING MARKET, BY END-USER, 2022-2031 (USD MILLION)

TABLE 126 PHILIPPINES HOSPITAL IN DEPRESSION SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 127 PHILIPPINES HOSPITAL IN DEPRESSION SCREENING MARKET, BY SIZE, 2022-2031 (USD MILLION)

TABLE 128 REST OF ASIA-PACIFIC DEPRESSION SCREENING MARKET, BY DEPRESSION TYPE, 2022-2031 (USD MILLION)

List of Figure

FIGURE 1 ASIA-PACIFIC DEPRESSION SCREENING MARKET: SEGMENTATION

FIGURE 2 ASIA-PACIFIC DEPRESSION SCREENING MARKET: DATA TRIANGULATION

FIGURE 3 ASIA-PACIFIC DEPRESSION SCREENING MARKET: DROC ANALYSIS

FIGURE 4 ASIA-PACIFIC DEPRESSION SCREENING MARKET: COUNTRY-WISE MARKET ANALYSIS

FIGURE 5 ASIA-PACIFIC DEPRESSION SCREENING MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 ASIA-PACIFIC DEPRESSION SCREENING MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 ASIA-PACIFIC DEPRESSION SCREENING MARKET: MARKET END-USER COVERAGE GRID

FIGURE 8 ASIA-PACIFIC DEPRESSION SCREENING MARKET: DBMR MARKET POSITION GRID

FIGURE 9 ASIA-PACIFIC DEPRESSION SCREENING MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 ASIA-PACIFIC DEPRESSION SCREENING MARKET: SEGMENTATION

FIGURE 11 ASIA-PACIFIC DEPRESSION SCREENING MARKET EXECUTIVE SUMMARY

FIGURE 12 STRATEGIC DECISIONS

FIGURE 13 THREE SEGMENTS COMPRISE THE ASIA-PACIFIC DEPRESSION SCREENING MARKET, BY DEPRESSION TYPE

FIGURE 14 INCREASING PREVALENCE OF DEPRESSION AND ANXIETY DISORDERS IS DRIVING THE GROWTH OF THE ASIA-PACIFIC DEPRESSION SCREENING MARKET FROM 2024 TO 2031

FIGURE 15 THE MAJOR DEPRESSIVE DISORDER (MDD) SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA-PACIFIC DEPRESSION SCREENING MARKET IN 2024 AND 2031

FIGURE 16 MARKET OVERVIEW

FIGURE 17 ASIA-PACIFIC DEPRESSION SCREENING MARKET: BY DEPRESSION TYPE, 2023

FIGURE 18 ASIA-PACIFIC DEPRESSION SCREENING MARKET: BY DEPRESSION TYPE, 2024-2031 (USD MILLION)

FIGURE 19 ASIA-PACIFIC DEPRESSION SCREENING MARKET: BY DEPRESSION TYPE, CAGR (2024-2031)

FIGURE 20 ASIA-PACIFIC DEPRESSION SCREENING MARKET: BY DEPRESSION TYPE, LIFELINE CURVE

FIGURE 21 ASIA-PACIFIC DEPRESSION SCREENING MARKET: BY DIAGNOSIS, 2023

FIGURE 22 ASIA-PACIFIC DEPRESSION SCREENING MARKET: BY DIAGNOSIS, 2024-2031 (USD MILLION)

FIGURE 23 ASIA-PACIFIC DEPRESSION SCREENING MARKET: BY DIAGNOSIS, CAGR (2024-2031)

FIGURE 24 ASIA-PACIFIC DEPRESSION SCREENING MARKET: BY DIAGNOSIS, LIFELINE CURVE

FIGURE 25 ASIA-PACIFIC DEPRESSION SCREENING MARKET: BY END-USER, 2023

FIGURE 26 ASIA-PACIFIC DEPRESSION SCREENING MARKET: BY END-USER, 2024-2031 (USD MILLION)

FIGURE 27 ASIA-PACIFIC DEPRESSION SCREENING MARKET: BY END-USER, CAGR (2024-2031)

FIGURE 28 ASIA-PACIFIC DEPRESSION SCREENING MARKET: BY END-USER, LIFELINE CURVE

FIGURE 29 ASIA-PACIFIC DEPRESSION SCREENING MARKET, SNAPSHOT (2023)

FIGURE 30 ASIA-PACIFIC DEPRESSION SCREENING MARKET: COMPANY SHARE 2023 (%)

Frequently Asked Questions

The market is segmented based on Asia-Pacific Depression Screening Market Segmentation, By Depression Type (Major Depressive Disorder (MDD), Persistent Depressive Disorder (PDD), and Others), Diagnosis (Screening and Lab Tests), End-User (Hospital, Specialty Clinics, Medical Research Centers, and Others) – Industry Trends and Forecast to 2031 .
The Asia Pacific Depression Screening Market size was valued at USD 679.81 USD Million in 2023.
The Asia Pacific Depression Screening Market is projected to grow at a CAGR of 10.6% during the forecast period of 2024 to 2031.
The market report covers data from the China, Japan, India, South Korea, Australia, Indonesia, Thailand, Singapore, Taiwan, Malaysia, Vietnam, Philippines, and Rest of Asia-Pacific.

Browse Related Pages

Banner